SEVERE HYPERTRIGLYCERIDEMIA
Clinical trials for SEVERE HYPERTRIGLYCERIDEMIA explained in plain language.
Never miss a new study
Get alerted when new SEVERE HYPERTRIGLYCERIDEMIA trials appear
Sign up with your email to follow new studies for SEVERE HYPERTRIGLYCERIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot every 3 months aims to slash dangerous fat levels in blood
Disease control OngoingThis study tests an injectable drug called plozasiran in 446 adults with severely high triglycerides (a type of fat in the blood). Participants receive either the drug or a placebo once every 3 months for a year. The goal is to see if the drug safely lowers triglyceride levels an…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
New drug shows promise for controlling dangerous fat levels in blood
Disease control OngoingThis study looks at the long-term safety of a drug called olezarsen for people with severe hypertriglyceridemia (very high blood fats). About 885 adults who completed a prior olezarsen study will receive the drug for up to 3 years while staying on their usual cholesterol-lowering…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
New shot could tame dangerous blood fats in phase 3 trial
Disease control OngoingThis study tests a new medicine called plozsiran in 311 adults with severely high triglycerides, a type of blood fat that raises the risk of heart problems. Participants receive four shots over a year, either the drug or a placebo, to see if it safely lowers their fat levels. The…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 14:03 UTC